Skip to content

Clinical trials

Phase 1/2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 1/2 Country / region: Netherlands Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Princess Maxima Center for Pediatric Oncology4
Therapeutic Advances in Childhood Leukemia Consortium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma5
Recurrence5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Lymphoma1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.